High platelet turnover and reactivity in renal transplant recipients patients

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Thrombosis and Haemostasis

• Publication date

  2010-08-05

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1160/TH10-02-0124PMID 20694276
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Platelet aggregability is modulated by eNOS locus in non-type 2 diabetic patients with acute coronary syndrome.

  2011cited by this paper
• Platelet aggregation in arterial hypertension: Is there a nitric oxide–urea connection?

  2010cited by this paper
• Assessment of platelet function on whole blood by multiple electrode aggregometry in high-risk patients with coronary artery disease receiving antiplatelet therapy.

  2009cited by this paper
• Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Detection, Evaluation, and Treatment of High Blood Cholesterol Education Program (NCEP) Expert Panel on Executive Summary of the Third Report of the National

  2009cited by this paper
• Relationship between high platelet turnover and platelet function in high-risk patients with coronary artery disease on dual antiplatelet therapy

  2008cited by this paper
• Thrombotic events in high risk patients are predicted by evaluating different pathways of platelet function

  2008cited by this paper
• Thrombospondin-1 in von Willebrand factor function.

  2008cited by this paper
• Incidence of aspirin resistance and its relationship with cardiovascular risk factors and graft function in renal transplant recipients.

  2008cited by this paper
• Reticulated platelets and uninhibited COX‐1 and COX‐2 decrease the antiplatelet effects of aspirin

  2007cited by this paper
• Cyclosporine enhances platelet procoagulant activity.

  2007cited by this paper
• Cardiovascular disease posttransplant.

  2007cited by this paper
• Inflammation and endothelial activation are linked to renal function in long‐term kidney transplantation

  2007cited by this paper
• Residual platelet reactivity is associated with clinical and laboratory characteristics in patients with ischemic heart disease undergoing PCI on dual antiplatelet therapy.

  2007cited by this paper
• Cardiovascular risk factors in renal transplantation--current controversies.

  2006cited by this paper
• A simple technique to determine thrombopoiesis level using immature platelet fraction (IPF).

  2006cited by this paper
• LOW-DOSE ASPIRIN THERAPY IS ASSOCIATED WITH IMPROVED ALLOGRAFT FUNCTION AND PROLONGED ALLOGRAFT SURVIVAL AFTER KIDNEY TRANSPLANTATION

  2004cited by this paper
• Assessment of an immature platelet fraction (IPF) in peripheral thrombocytopenia

  2004cited by this paper
• Role of Thrombospondin-1 in Control of von Willebrand Factor Multimer Size in Mice*

  2004cited by this paper
• A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease.

  2003cited by this paper
• Practice guidelines for primary care physicians: 2003 ESH/ESC hypertension guidelines.

  2003cited by this paper
• C-reactive protein, arterial endothelial activation, and development of transplant coronary artery disease: a prospective study.

  2002cited by this paper
• Effects of immunosuppressive drugs on platelet aggregation in vitro.

  2002cited by this paper
• Determinants of enhanced thromboxane biosynthesis in renal transplantation.

  2001cited by this paper
• A possible role of thrombin-activatable fibrinolysis inhibitor in disturbances of fibrinolytic system in renal transplant recipients.

  2001cited by this paper
• Explained and unexplained ischemic heart disease risk after renal transplantation.

  2000cited by this paper
• Recommendations for the outpatient surveillance of renal transplant recipients. American Society of Transplantation.

  2000cited by this paper
• Assignment1 of the human PHLDA1 gene to chromosome 12q15 by radiation hybrid mapping

  2000cited by this paper
• Effects of erythropoietin on platelet reactivity and thrombopoiesis in humans.

  2000cited by this paper
• The role of the graft endothelium in transplant rejection: Evidence that endothelial activation may serve as a clinical marker for the development of chronic rejection

  2000cited by this paper
• Risk factors for cardiovascular disease in renal transplant recipients: new insights

  2000cited by this paper
• Report of the expert committee on the diagnosis and classification of diabetes mellitus.

  1999cited by this paper
• Thrombopoietin and thrombospondin in renal allograft recipients.

  1999cited by this paper
• Megakaryocytic differentiation of HIMeg-1 cells induced by interferon gamma and tumour necrosis factor alpha but not by thrombopoietin.

  1998cited by this paper
• Clinical epidemiology of cardiovascular disease in chronic renal disease.

  1998cited by this paper
• Effect of recombinant human erythropoietin treatment on circulating reticulated platelets in uremic patients: Association with early improvement in platelet function

  1998cited by this paper
• CD40 and CD40 ligand (CD154) are coexpressed on microvessels in vivo in human cardiac allograft rejection.

  1997cited by this paper
• Early endothelial dysfunction predicts the development of transplant coronary artery disease at 1 year posttransplant.

  1996cited by this paper
• Hypertension and ischaemic heart disease in renal transplant recipients.

  1995cited by this paper
• Evidence for abnormal platelet glycoprotein expression in diabetes mellitus

  1990cited by this paper
• The biological significance of platelet volume: its relationship to bleeding time, platelet thromboxane B2 production and megakaryocyte nuclear DNA concentration.

  1983cited by this paper
• Arachidonic acid metabolism by platelets of differing size

  1983cited by this paper

• Immature platelet fraction: A useful marker for identifying the cause of thrombocytopenia and predicting platelet recovery

  2020cites this paper
• Reticulated platelets – clinical application and future perspectives

  2020cites this paper
• Reticulated platelets and immature platelet fraction: Clinical applications and method limitations

  2020cites this paper
• Successful kidney transplantation normalizes platelet function

  2018cites this paper
• New Blood Cell Counting Technology in the VCUHS Hematology Laboratory

  2017cites this paper
• Time-Dependent Decay of mRNA and Ribosomal RNA during Platelet Aging and Its Correlation with Translation Activity

  2016cites this paper
• Evaluation of the immature platelet fraction in the diagnosis and prognosis of childhood immune thrombocytopenia

  2015cites this paper
• Clinical applicability of reticulated platelets.

  2015cites this paper
• Correlation Between the CYP2C19 Phenotype Status and the Results of Three Different Platelet Function Tests in Cardiovascular Disease Patients Receiving Antiplatelet Therapy: An Emphasis on Newly Introduced Platelet Function Analyzer-200 P2Y Test

  2015cites this paper
• Platelet count and function in paediatric cardiac surgery: a prospective observational study.

  2014cites this paper
• Stress-induced hyperviscosity in the pathophysiology of takotsubo cardiomyopathy.

  2013cites this paper
• Thrombotic microangiopathy: A role for magnesium?

  2012cites this paper
• Platelet-associated hypercoagulability in patients with Essential Thrombocythemia and Polycythemia Vera

  2012cites this paper
• Immature platelet fraction (IPF) determined with an automated method predicts clopidogrel hyporesponsiveness

  2012cites this paper
• ANTICORPOS EM TRANSPLANTADOS RENAIS

  2011cites this paper
• JAK2V617F mutation and hydroxyurea treatment as determinants of immature platelet parameters in essential thrombocythemia and polycythemia vera patients.

  2011cites this paper